Scientific committee

Prof. Dr. Aleksandra Szczepankiewicz

Poznań University of Medical Sciences

Prof. Aleksandra Szczepankiewicz is the Head of the Centre for Experimental Medicine and the Department of Experimental Biology at Poznań University of Medical Sciences, Poland. Her research focuses on the molecular mechanisms underlying asthma and other respiratory diseases, with particular emphasis on the role of non-coding RNAs in airway inflammation, immune regulation, and tissue repair. Her work also involves the development and application of experimental models to identify novel diagnostic biomarkers and potential therapeutic targets.

Prof. Szczepankiewicz has authored over 100 scientific publications and served as principal investigator in numerous research projects. She completed a postdoctoral fellowship at the University of Southampton and has received several prestigious distinctions, including the L’Oréal–UNESCO For Women in Science Award. She is also actively involved in the European Respiratory Society and contributes to the training and supervision of early-career researchers.

Prof. Dr. Tomasz Osmałek

Poznań University of Medical Sciences

Tomasz Osmałek is Professor of Pharmaceutical Sciences, Head of the Department of Pharmaceutical Technology, and Vice-Dean for Research at PUMS. He also serves as Vice-President of the CRS Poland Local Chapter. His research focuses on pharmaceutical formulation and drug delivery, particularly topical and transdermal systems, microneedles, polymer-based formulations, and 3D printing. He has been involved in several international research projects and collaborations and has completed research stays at Rutgers University and the University of Central Florida. His international experience also includes research visits and ongoing collaborations with Queen’s University Belfast, Riga Stradiņš University, and Aristotle University of Thessaloniki, mainly in the areas of pharmaceutical technology and advanced drug delivery systems.



Prof. Dr. Špela Zupančič

University of Ljubljana

Špela Zupančič is an Associate Professor of Pharmaceutical Nanotechnology at the Faculty of Pharmacy, University of Ljubljana, Slovenia. She obtained her PhD in 2017 and gained international research experience at University College London, the University of Illinois Chicago, and Rutgers, The State University of New Jersey. Her research focuses on electrospun nanofibers incorporating drugs and probiotics, lipid nanoparticles, and vesicular delivery systems, including extracellular vesicles, with particular emphasis on their potential for treating vaginal infections and periodontal disease.

Dr. Natalia Rozwadowska

Institute of Human Genetics, Polish Academy of Sciences (IHG PAS)

Professor Natalia Rozwadowska is a biomedical scientist specializing in human genetics, stem cell biology, and advanced cell and gene therapies. She serves as Head of the Department of Molecular Pathology and Deputy Director for Development at the Institute of Human Genetics, Polish Academy of Sciences.

Her research focuses on the application of stem cells, particularly induced pluripotent stem cells (iPSCs), in disease modeling, regenerative medicine, and the development of innovative therapeutic strategies. Bridging academic research and biotechnology, she is actively involved in translational projects aimed at advancing Advanced Therapy Medicinal Products (ATMPs), including genetically engineered cell therapies such as CAR-T cells. Her work contributes to the development of Poland's emerging cell and gene therapy ecosystem, connecting scientific innovation with clinical translation and biotechnology-driven product development.

Her scientific and professional achievements have been recognized with several prestigious distinctions, including TOP 10 Women in Biotech, the Polka XXI Wieku Award in the Health category and two Prime Minister's Awards for outstanding scientific achievements.

Beyond her research and leadership roles, Professor Rozwadowska is committed to science communication and public engagement. She founded Gen-i-już, an association dedicated to promoting genetics and biomedical sciences among young people, whose educational initiatives reach nearly 1,000 participants annually.

Through her combined academic, translational, and leadership activities, she is dedicated to accelerating the translation of biomedical discoveries into innovative therapies and strengthening collaboration between academia, industry, and clinical medicine

Dr. Krzysztof Szczepanowicz

Instytut Katalizy i Fizykochemii Powierzchni PAN im. Jerzego Habera

Krzysztof Szczepanowicz is an Associate Professor at the Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, in Kraków, Poland, where he leads the Nanostructures of Soft Matter Group and the Laboratory of Nanotechnology. His research focuses on the design, fabrication, and physicochemical characterization of functional nanostructured materials, with particular emphasis on layer-by-layer assembly, polyelectrolyte nanocapsules, and polymeric drug delivery systems. His work combines surface and interface engineering with the development of multifunctional nanocarriers for controlled drug release and biomedical applications.

Dr hab. Jolanta Długaszewska

Poznań University of Medical Sciences

Jolanta Długaszewska is an experienced researcher in the fields of medical and pharmaceutical microbiology. Her scholarly output comprises over 100 peer-reviewed publications. Her research focused on medical microbiology and infection control, microbiological quality of pharmaceutical products, biology of microbial biofilms. In recent years, her research has expanded into interdisciplinary antimicrobial innovation, particularly the evaluation of biosynthesized metal nanoparticles, photodynamic and sonodynamic therapy agents. Through collaborations with chemists and materials scientists, she has contributed to high-impact studies on the antimicrobial and antibiofilm properties of nanomaterials, photosensitizers and sonosensitizers, published in internationally recognized journals.


Dr. Agnieszka Piegat

West Pomeranian University of Technology in Szczecin

Dr. Eng. Agnieszka Piegat is a researcher at the West Pomeranian University of Technology in Szczecin, Poland, specializing in the design and development of polymer-based biomaterials for biomedical applications. Her research focuses on natural polymers, particularly chitosan, as versatile materials for drug delivery systems. She investigates the development, modification, and characterization of chitosan-based materials with tailored properties for controlled drug release and potential therapeutic applications. Her scientific interests lie at the intersection of polymer chemistry, biomaterials science, and drug delivery, contributing to the development of innovative, biocompatible material platforms for advanced pharmaceutical and biomedical applications.

Dr. Grzegorz Garbacz

Physiolution GmbH, Poznań University of Medical Sciences

His research focuses on biorelevant dissolution testing, gastrointestinal tract simulation, and the development of innovative methods for evaluating oral drug delivery systems. His work particularly involves designing experimental models that reproduce physiological conditions in the gastrointestinal tract, enabling more accurate predictions of drug release and performance in vivo.

Contact

Controlled Release Society Oddział Lokalny w Polsce
ul. Rokietnicka 3 / B.1.1.12
60-806 Poznań, Polska

Email: crspoland@ump.edu.pl

Send us a message
Page created with the event management system SF-CONFERENCE - Privacy policy, Accessibility statement